Standout Papers

Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes 2008 2026 2014 2020 663
  1. Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes (2008)
    Björn Zethelius, Lars Berglund et al. New England Journal of Medicine
  2. Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men (2009)
    Johan Ärnlöv, Erik Ingelsson et al. Circulation
  3. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data (2014)
    Johan Sundström The Lancet
  4. Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis (2016)
    Jason Wu, Celine Foote et al. The Lancet Diabetes & Endocrinology
  5. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort (2021)
    Tracey G. Simon, Björn Roelstraete et al. Gut
  6. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study (2022)
    Johan Sundström, Johan Bodegård et al. The Lancet Regional Health - Europe
  7. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data (2021)
    Gemma A. Figtree, Stephen T. Vernon et al. The Lancet
  8. Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden (2021)
    Jonas F. Ludvigsson, Peter Appelros et al. Clinical Epidemiology
  9. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction (2024)
    Troels Yndigegn, Bertil Lindahl et al. New England Journal of Medicine

Immediate Impact

81 standout
Sub-graph 1 of 16

Citing Papers

Obesity in adults
2024 Standout
Steatotic liver disease
2024 Standout
4 intermediate papers

Works of Johan Sundström being referenced

Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease
2022
Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort
2021 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Johan Sundström 6685 3018 2528 2679 354 16.4k
Nish Chaturvedi 5882 6213 1865 2458 402 18.7k
Johan Ärnlöv 4149 1983 1509 2138 300 12.3k
Anna F. Dominiczak 9543 3862 2807 3444 344 21.5k
Jacqueline C.M. Witteman 5236 2093 2179 1959 170 15.8k
Aroon D. Hingorani 7006 3534 4598 2781 265 25.6k
Wendy S. Post 9341 2623 3284 1385 423 19.4k
Giel Nijpels 4975 6422 2004 2989 406 19.5k
Susan R. Heckbert 9711 3742 2418 1444 474 21.0k
Chim C. Lang 8548 2916 2523 1833 382 15.5k
Bonita Falkner 9145 3233 2602 2339 228 17.6k

All Works

Loading papers...

Rankless by CCL
2026